Yantasee, Wassana and Fryxell, Glen E. and Porter, George A. and Pattamakomsan, Kanda and Sukwarotwat, Vichaya and Chouyyok, Wilaiwan and Koonsiripaiboon, View and Xu, Jide and Raymond, Kenneth N. (2010) Novel sorbents for removal of gadolinium-based contrast agents in sorbent dialysis and hemoperfusion: preventive approaches to nephrogenic systemic fibrosis. Nanomedicine: Nanotechnology, Biology and Medicine, 6 (1). 1 - 8.
Official URL: http://www.sciencedirect.com/science/article/B7MDB...
Many forms of organocomplexed gadolinium (Gd) contrast agents have recently been linked to a debilitating and a potentially fatal skin disease called nephrogenic systemic fibrosis (NSF) in patients with renal failure. Free Gd released from these complexes via transmetallation is believed to be the most important trigger for NSF. In this work, nanostructure silica materials that have been functionalized with 1-hydroxy-2-pyridinone (1,2-HOPO-SAMMS) have been evaluated for selective and effective removal of both free and chelated Gd (gadopentetate dimeglumine and gadodiamide) from dialysate and blood. 1,2-HOPO SAMMS has high affinity, rapid removal rate, and large sorption capacity for both free and chelated Gd, properties that are far superior to those of activated carbon and zirconium phosphate currently used in the state-of-the-art sorbent dialysis and hemoperfusion systems. The SAMMS-based sorbent dialysis and hemoperfusion will potentially provide an effective and predicable strategy for removing the Gd from patients with impaired renal function after Gd exposure, thus allowing for the continued use of Gd-based contrast magnetic resonance imaging while removing the risk of NSF.
|Uncontrolled Keywords:||Contrast agent; Gadolinium; Hemoperfusion; Hydroxyl pyridinone; NSF; SAMMS; Sorbent dialysis|
|Subjects:||Biomedical Science > Nanomedicine|
|Deposited On:||22 Apr 2010 10:52|
|Last Modified:||22 Apr 2010 10:52|
Repository Staff Only: item control page